SYNARC Launches Educational Webinar Series

Newark, CA – September 09, 2011 – SYNARC, the world’s leading provider of medical imaging services for the pharmaceutical, biotechnology, and medical device industries, announced today that the first in its series of complimentary educational webinars will be conducted on The Use of Cardiac Magnetic Resonance (CMR) in Clinical Trials.  The webinar will be presented on Wednesday, September 21st at 12PM – 2PM EST (9AM – 11AM PST). Our complimentary series is designed to help participants better understand the benefits of using imaging for clinical trials and will cover a range of topics and therapeutic areas.

The webinar will be presented by Albert C. Lardo, PhD, FAHA, FACC, Associate Professor of Medicine and Biomedical Engineering, Division of Cardiology, at Johns Hopkins School of Medicine.  In the field of cardiovascular imaging technology and therapy, Dr. Lardo has authored over 70 peer reviewed manuscripts and acquired 20 patents. Professor Lardo is a member of SYNARC’s Scientific Advisory Board for Cardiology and is a key opinion leader in the use of CMR and CT myocardial imaging in ischemic heart disease.

To register for this webinar, paste the following link into your browser: https://cc.callinfo.com/r/1wm3rhnjwlpxo or go to our home page at www.synarc.com.

About SYNARC

SYNARC has extensive expertise in cardiovascular imaging services including angiography, echocardiography, cardiac MRI, carotid intima media thickness (CIMT), intravascular ultrasound (IVUS) and other modalities to support cardiovascular clinical programs, as well as cardiac safety assessments in other therapeutic areas such as oncology and metabolic diseases.  SYNARC continues to make progress in building its cardiovascular franchise and in particular, to broaden the range of imaging modalities it offers its clients for use in clinical trials. 

# # #
Contact:
Joy Valderrama
415 817-8919
joy.valderrama@synarc.com